| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |